• SENSEX 73,694.89
    448.86 (+0.61%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,380.50 1,356.40(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • PTC Industries
    24,750.00 26,049.95(%)
  • NSE
    1,795.00 1,878.00(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,176.50 1,108.20(%)
  • Billionbrains
    189.10 112.02(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    932.45 1,177.60(%)
  • Birlasoft Ltd
    351.80 473.75(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Adani Ports
    1,857.40 1,891.80(%)
  • Coromandel Inter
    1,734.65 2,496.10(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • JSW Dulux
    286.50 374.67(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Moneyview
    52.44 65.43(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Roopa Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Sree Rayalseema
  • BSE Code : 5239.0
  • ISIN : INE443C01010
42.60 0 (-0.91%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    42.60

  • Today’s High

    42.99

  • Open

    42.99

  • Perv Close

    42.99

  • 52W Low

    38.10

  • 52W High

    63.40

Key Indicators

  • P/E(TTM)

    7.95

  • Mar.Cap (₹Cr.)

    33.51

  • Div & Yield %

    0.00

  • Book Value(₹)

    22.37

  • Debt-Equity Ratio

    -0.91

  • AGM Date

    28-Oct-2026

  • EPS

    5.36

  • P/E Ratio

    7.95

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    33.51

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.87

  • BV (₹)

    22.40

  • Sales( ₹ in Cr.)

    127.50

  • NP (in Cr.)

    4.17

  • NP Var(%)

    113.0

  • Div%

    0.0

  • CPS (₹)

    6.30

  • EPS (₹)

    5.30

  • Traded Value (₹ in Lakhs)

    33.51

  • 52 Week High

    63.40

  • 52 Week Low

    38.10

  • Price BSE

    43.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    33.51

  • P/C Ratio

    6.80

  • P/E Ratio

    8.10

  • Price Vs.BV

    5.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 127.50 120.69 70.43 76.17 51.21 28.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 127.50 120.69 70.43 76.17 51.21 28.61
Other Income 0.13 2.30 1.13 0.65 0.06 0.08
Stock Adjustments -0.11 4.98 9.75 3.64 -6.68 4.88
Total Income 127.52 127.97 81.31 80.46 44.59 33.57
EXPENDITURE :            
Raw Materials 110.26 114.42 64.37 65.12 33.17 22.23
Power and Fuel Cost 1.28 1.13 2.87 2.71 1.90 2.14
Employee Cost 2.93 2.83 3.47 3.24 2.21 3.77
Other Manufacturing Expenses 1.16 0.94 2.32 2.48 1.97 1.20
Selling and Administration Expenses 3.00 1.86 2.05 1.71 1.30 1.26
Miscellaneous Expenses 4.70 0.37 0.65 0.65 0.54 0.16
Employee Benefit Expenses 2.93 2.83 3.47 3.24 2.21 3.77
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 123.34 121.55 75.73 75.92 41.08 30.77
Operating Profit 4.18 6.42 5.57 4.54 3.50 2.80
Interest 3.22 2.84 2.52 1.84 1.21 1.06
Gross Profit 0.96 3.58 3.05 2.70 2.29 1.74
Depreciation 0.80 0.85 0.87 0.89 0.93 0.81
Profit Before Tax 0.16 2.73 2.18 1.81 1.36 0.93
Current Tax 0.11 0.77 0.66 0.44 0.40 0.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.02 -0.08 -0.01 0.01 -0.05 0.00
Reported Net Profit 0.08 2.03 1.52 1.35 1.02 0.72
Extraordinary Items -4.09 0.08 0.08 0.00 0.00 0.00
Adjusted Net Profit 4.17 1.95 1.44 1.35 1.02 0.72
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 9.06 7.03 5.51 4.16 2.91 2.20
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 9.15 9.06 7.03 5.51 3.93 2.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.11 2.59 1.93 1.72 1.29 0.91
Earnings Per Share(Adj)-Unit Curr 0.11 2.59 1.93 1.72 1.29 0.91
Book Value 22.37 22.24 19.67 17.73 16.00 14.70
Book Value(Adj)-Unit Curr 22.37 22.24 19.67 17.73 16.00 14.70

Shareholding Pattern

  • Promoter Group

    48.03%

  • Public Share Holding

    51.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,913,617 37.04 2,913,617 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 864,047 10.99 864,047 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,777,664 48.03 3,777,664 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 20,000 0.25 0 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,250 0.26 250 2
2] Non Institution
Bodies Corporate 230,283 2.93 71,483 41
Clearing Members 900 0.01 900 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 614,755 7.82 74,155 219
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,418,767 18.04 1,354,367 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,802,901 22.92 1,207,331 3,616
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,067,606 51.71 2,708,236 3,887
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,865,520 100.00 6,486,150 3,894

Company Background

Roopa Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Roopa Industries Ltd
  • BSE Code : 5239.0
  • ISIN : INE443C01010

  • Incorporation Year

    1985

  • Registered Office

    17/745 Alur Road
    Kurnool District, ADONI,
    Andhra Pradesh-518301

  • Telephone

  • FAX

    91-40-23310379

  • Chairman

    T G Raghavendra

  • Managing Director

    T G Raghavendra

  • Company Secretary

    VENKATA LAKSHMI INDANI

  • Auditor

    Yelamanchi & Associates.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Roopa Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Roopa Industries 42.60 127.64 127.50 266.25 14.87
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77